OSTEOGENIC GROWTH PEPTIDE (10-14)
中文名称 | OSTEOGENIC GROWTH PEPTIDE (10-14) |
---|---|
中文同义词 | |
英文名称 | H-TYR-GLY-PHE-GLY-GLY-OH |
英文同义词 | OSTEOGENIC GROWTH PEPTIDE (10-14);OGP (10-14);H-TYR-GLY-PHE-GLY-GLY-OH;historphin;Glycine, N-(N-(N-(N-L-tyrosylglycyl)-L-phenylalanyl)glycyl)-;Tyr-Gly-Phe-Gly-gly;Tyrosyl-glycyl-phenylalanyl-glycyl-glycine;Glycine, L-tyrosylglycyl-L-phenylalanylglycyl- |
CAS号 | 105250-85-9 |
分子式 | C24H29N5O7 |
分子量 | 499.52 |
EINECS号 | |
相关类别 | 目录肽;标准品 |
Mol文件 | 105250-85-9.mol |
结构式 |
OSTEOGENIC GROWTH PEPTIDE (10-14) 性质
沸点 | 1028.0±65.0 °C(Predicted) |
---|---|
密度 | 1.352±0.06 g/cm3(Predicted) |
储存条件 | Store at -20°C |
溶解度 | 溶于二甲基亚砜 |
酸度系数(pKa) | 3.32±0.10(Predicted) |
Osteogenic Growth Peptide (10-14) (OGP(10-14)) induces proliferation and differentiation in fibroblast and osteoblast cell lines.
Osteogenic Growth Peptide (10-14) induces TPO-primed M07-e cells differentiation through RhoA/TGFβ1/SFKs signalling pathway. In particular Historphin acts as a Src inhibitor, showing the same effects of PP2.
Osteogenic Growth Peptide (10-14) (OGP(10-14)) increases bone formation and trabecular bone density and stimulates fracture healing when administered to mice and rats.
安全信息
更新日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
---|---|---|---|---|---|
2024/04/30 | HY-107024 | OSTEOGENIC GROWTH PEPTIDE (10-14) Osteogenic Growth Peptide (10-14) | 105250-85-9 | 1mg | 500元 |
2024/04/30 | HY-107024 | OSTEOGENIC GROWTH PEPTIDE (10-14) Osteogenic Growth Peptide (10-14) | 105250-85-9 | 5mg | 1250元 |